nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—Seasonal allergy—Metformin—type 2 diabetes mellitus	0.0369	0.0523	CcSEcCtD
Methacholine—Rhinitis seasonal—Metformin—type 2 diabetes mellitus	0.0355	0.0502	CcSEcCtD
Methacholine—Seasonal allergy—Irbesartan—type 2 diabetes mellitus	0.0349	0.0494	CcSEcCtD
Methacholine—Rhinitis seasonal—Irbesartan—type 2 diabetes mellitus	0.0335	0.0474	CcSEcCtD
Methacholine—L-Carnitine—CPT1A—type 2 diabetes mellitus	0.026	1	CrCbGaD
Methacholine—Pregnancy—Pioglitazone—type 2 diabetes mellitus	0.0226	0.032	CcSEcCtD
Methacholine—Respiratory distress—Metformin—type 2 diabetes mellitus	0.0122	0.0173	CcSEcCtD
Methacholine—Respiratory distress—Irbesartan—type 2 diabetes mellitus	0.0115	0.0163	CcSEcCtD
Methacholine—Respiratory distress—Losartan—type 2 diabetes mellitus	0.0108	0.0153	CcSEcCtD
Methacholine—Lightheadedness—Bromocriptine—type 2 diabetes mellitus	0.0101	0.0143	CcSEcCtD
Methacholine—Chest discomfort—Metformin—type 2 diabetes mellitus	0.00875	0.0124	CcSEcCtD
Methacholine—Cough—Linagliptin—type 2 diabetes mellitus	0.00762	0.0108	CcSEcCtD
Methacholine—Cough—Nateglinide—type 2 diabetes mellitus	0.00713	0.0101	CcSEcCtD
Methacholine—Wheezing—Irbesartan—type 2 diabetes mellitus	0.0071	0.0101	CcSEcCtD
Methacholine—Lightheadedness—Metformin—type 2 diabetes mellitus	0.00693	0.00981	CcSEcCtD
Methacholine—Lightheadedness—Irbesartan—type 2 diabetes mellitus	0.00654	0.00926	CcSEcCtD
Methacholine—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.00639	0.00905	CcSEcCtD
Methacholine—Chest pain—Repaglinide—type 2 diabetes mellitus	0.00602	0.00853	CcSEcCtD
Methacholine—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.00576	0.00817	CcSEcCtD
Methacholine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.0056	0.00793	CcSEcCtD
Methacholine—Lightheadedness—Ramipril—type 2 diabetes mellitus	0.00528	0.00747	CcSEcCtD
Methacholine—Syncope—Glipizide—type 2 diabetes mellitus	0.00525	0.00744	CcSEcCtD
Methacholine—Nausea—Miglitol—type 2 diabetes mellitus	0.00523	0.00741	CcSEcCtD
Methacholine—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00518	0.00735	CcSEcCtD
Methacholine—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.00515	0.00729	CcSEcCtD
Methacholine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.0051	0.00722	CcSEcCtD
Methacholine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.0051	0.00722	CcSEcCtD
Methacholine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00496	0.00703	CcSEcCtD
Methacholine—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.0048	0.0068	CcSEcCtD
Methacholine—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.00477	0.00676	CcSEcCtD
Methacholine—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00476	0.00675	CcSEcCtD
Methacholine—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00476	0.00675	CcSEcCtD
Methacholine—Cough—Sitagliptin—type 2 diabetes mellitus	0.00475	0.00673	CcSEcCtD
Methacholine—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00473	0.0067	CcSEcCtD
Methacholine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00472	0.00669	CcSEcCtD
Methacholine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.0047	0.00666	CcSEcCtD
Methacholine—Shock—Glipizide—type 2 diabetes mellitus	0.0047	0.00666	CcSEcCtD
Methacholine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00458	0.00649	CcSEcCtD
Methacholine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00451	0.00639	CcSEcCtD
Methacholine—Headache—Tolazamide—type 2 diabetes mellitus	0.00451	0.00639	CcSEcCtD
Methacholine—Headache—Linagliptin—type 2 diabetes mellitus	0.00446	0.00633	CcSEcCtD
Methacholine—Syncope—Bromocriptine—type 2 diabetes mellitus	0.00442	0.00626	CcSEcCtD
Methacholine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00441	0.00625	CcSEcCtD
Methacholine—Vomiting—Acarbose—type 2 diabetes mellitus	0.0044	0.00623	CcSEcCtD
Methacholine—Shock—Glimepiride—type 2 diabetes mellitus	0.00439	0.00621	CcSEcCtD
Methacholine—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.00433	0.00614	CcSEcCtD
Methacholine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00428	0.00606	CcSEcCtD
Methacholine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00428	0.00606	CcSEcCtD
Methacholine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00424	0.00601	CcSEcCtD
Methacholine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00417	0.0059	CcSEcCtD
Methacholine—Nausea—Acarbose—type 2 diabetes mellitus	0.00411	0.00582	CcSEcCtD
Methacholine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00409	0.00579	CcSEcCtD
Methacholine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00396	0.00561	CcSEcCtD
Methacholine—Bradycardia—Metformin—type 2 diabetes mellitus	0.00396	0.00561	CcSEcCtD
Methacholine—Shock—Bromocriptine—type 2 diabetes mellitus	0.00396	0.00561	CcSEcCtD
Methacholine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00386	0.00547	CcSEcCtD
Methacholine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00376	0.00532	CcSEcCtD
Methacholine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00374	0.00529	CcSEcCtD
Methacholine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00367	0.0052	CcSEcCtD
Methacholine—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00364	0.00516	CcSEcCtD
Methacholine—Headache—Repaglinide—type 2 diabetes mellitus	0.00362	0.00513	CcSEcCtD
Methacholine—Shock—Glyburide—type 2 diabetes mellitus	0.00362	0.00513	CcSEcCtD
Methacholine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00361	0.00511	CcSEcCtD
Methacholine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.00356	0.00504	CcSEcCtD
Methacholine—Cough—Gliclazide—type 2 diabetes mellitus	0.00353	0.005	CcSEcCtD
Methacholine—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00344	0.00488	CcSEcCtD
Methacholine—Hypotension—Glyburide—type 2 diabetes mellitus	0.00344	0.00487	CcSEcCtD
Methacholine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00343	0.00486	CcSEcCtD
Methacholine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00342	0.00484	CcSEcCtD
Methacholine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00338	0.00479	CcSEcCtD
Methacholine—Syncope—Valsartan—type 2 diabetes mellitus	0.00333	0.00472	CcSEcCtD
Methacholine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00327	0.00463	CcSEcCtD
Methacholine—Cough—Valsartan—type 2 diabetes mellitus	0.00324	0.00459	CcSEcCtD
Methacholine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00324	0.00459	CcSEcCtD
Methacholine—Cough—Orlistat—type 2 diabetes mellitus	0.0032	0.00454	CcSEcCtD
Methacholine—Chest pain—Valsartan—type 2 diabetes mellitus	0.00316	0.00448	CcSEcCtD
Methacholine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00316	0.00448	CcSEcCtD
Methacholine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00315	0.00447	CcSEcCtD
Methacholine—Chest pain—Orlistat—type 2 diabetes mellitus	0.00313	0.00443	CcSEcCtD
Methacholine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00309	0.00437	CcSEcCtD
Methacholine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00304	0.0043	CcSEcCtD
Methacholine—Syncope—Metformin—type 2 diabetes mellitus	0.00304	0.0043	CcSEcCtD
Methacholine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00303	0.00429	CcSEcCtD
Methacholine—Headache—Glipizide—type 2 diabetes mellitus	0.00299	0.00424	CcSEcCtD
Methacholine—Shock—Valsartan—type 2 diabetes mellitus	0.00298	0.00423	CcSEcCtD
Methacholine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00297	0.00421	CcSEcCtD
Methacholine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00295	0.00418	CcSEcCtD
Methacholine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00294	0.00416	CcSEcCtD
Methacholine—Chest pain—Metformin—type 2 diabetes mellitus	0.00288	0.00408	CcSEcCtD
Methacholine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00287	0.00406	CcSEcCtD
Methacholine—Syncope—Irbesartan—type 2 diabetes mellitus	0.00286	0.00406	CcSEcCtD
Methacholine—Nausea—Glipizide—type 2 diabetes mellitus	0.00284	0.00402	CcSEcCtD
Methacholine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00283	0.00402	CcSEcCtD
Methacholine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00283	0.00402	CcSEcCtD
Methacholine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00283	0.004	CcSEcCtD
Methacholine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00281	0.00398	CcSEcCtD
Methacholine—Headache—Glimepiride—type 2 diabetes mellitus	0.00279	0.00396	CcSEcCtD
Methacholine—Cough—Irbesartan—type 2 diabetes mellitus	0.00279	0.00395	CcSEcCtD
Methacholine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00278	0.00394	CcSEcCtD
Methacholine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00272	0.00385	CcSEcCtD
Methacholine—Shock—Metformin—type 2 diabetes mellitus	0.00272	0.00385	CcSEcCtD
Methacholine—Syncope—Losartan—type 2 diabetes mellitus	0.0027	0.00382	CcSEcCtD
Methacholine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00266	0.00377	CcSEcCtD
Methacholine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00265	0.00375	CcSEcCtD
Methacholine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00264	0.00374	CcSEcCtD
Methacholine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00264	0.00374	CcSEcCtD
Methacholine—Cough—Losartan—type 2 diabetes mellitus	0.00262	0.00372	CcSEcCtD
Methacholine—Pruritus—Glyburide—type 2 diabetes mellitus	0.0026	0.00369	CcSEcCtD
Methacholine—Hypotension—Metformin—type 2 diabetes mellitus	0.00258	0.00366	CcSEcCtD
Methacholine—Shock—Irbesartan—type 2 diabetes mellitus	0.00256	0.00363	CcSEcCtD
Methacholine—Chest pain—Losartan—type 2 diabetes mellitus	0.00256	0.00363	CcSEcCtD
Methacholine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00256	0.00362	CcSEcCtD
Methacholine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00252	0.00357	CcSEcCtD
Methacholine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00244	0.00345	CcSEcCtD
Methacholine—Shock—Losartan—type 2 diabetes mellitus	0.00241	0.00342	CcSEcCtD
Methacholine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00239	0.00338	CcSEcCtD
Methacholine—Vomiting—Glyburide—type 2 diabetes mellitus	0.00234	0.00331	CcSEcCtD
Methacholine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00234	0.00331	CcSEcCtD
Methacholine—Syncope—Ramipril—type 2 diabetes mellitus	0.00231	0.00327	CcSEcCtD
Methacholine—Headache—Glyburide—type 2 diabetes mellitus	0.0023	0.00326	CcSEcCtD
Methacholine—Hypotension—Losartan—type 2 diabetes mellitus	0.00229	0.00325	CcSEcCtD
Methacholine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00227	0.00321	CcSEcCtD
Methacholine—Cough—Ramipril—type 2 diabetes mellitus	0.00225	0.00319	CcSEcCtD
Methacholine—Chest pain—Ramipril—type 2 diabetes mellitus	0.00219	0.00311	CcSEcCtD
Methacholine—Nausea—Glyburide—type 2 diabetes mellitus	0.00218	0.00309	CcSEcCtD
Methacholine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00218	0.00309	CcSEcCtD
Methacholine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00215	0.00304	CcSEcCtD
Methacholine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00212	0.003	CcSEcCtD
Methacholine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.0021	0.00297	CcSEcCtD
Methacholine—Shock—Ramipril—type 2 diabetes mellitus	0.00207	0.00293	CcSEcCtD
Methacholine—Headache—Gliclazide—type 2 diabetes mellitus	0.00207	0.00293	CcSEcCtD
Methacholine—Dizziness—Valsartan—type 2 diabetes mellitus	0.00201	0.00284	CcSEcCtD
Methacholine—Dizziness—Orlistat—type 2 diabetes mellitus	0.00198	0.00281	CcSEcCtD
Methacholine—Hypotension—Ramipril—type 2 diabetes mellitus	0.00197	0.00278	CcSEcCtD
Methacholine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00196	0.00278	CcSEcCtD
Methacholine—Pruritus—Metformin—type 2 diabetes mellitus	0.00195	0.00277	CcSEcCtD
Methacholine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00193	0.00273	CcSEcCtD
Methacholine—Vomiting—Orlistat—type 2 diabetes mellitus	0.00191	0.0027	CcSEcCtD
Methacholine—Headache—Valsartan—type 2 diabetes mellitus	0.0019	0.00269	CcSEcCtD
Methacholine—Headache—Orlistat—type 2 diabetes mellitus	0.00188	0.00266	CcSEcCtD
Methacholine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00184	0.00261	CcSEcCtD
Methacholine—Dizziness—Metformin—type 2 diabetes mellitus	0.00183	0.00259	CcSEcCtD
Methacholine—Nausea—Valsartan—type 2 diabetes mellitus	0.0018	0.00255	CcSEcCtD
Methacholine—Nausea—Orlistat—type 2 diabetes mellitus	0.00178	0.00252	CcSEcCtD
Methacholine—Vomiting—Metformin—type 2 diabetes mellitus	0.00176	0.00249	CcSEcCtD
Methacholine—Pruritus—Losartan—type 2 diabetes mellitus	0.00174	0.00246	CcSEcCtD
Methacholine—Headache—Metformin—type 2 diabetes mellitus	0.00173	0.00245	CcSEcCtD
Methacholine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00172	0.00244	CcSEcCtD
Methacholine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00166	0.00235	CcSEcCtD
Methacholine—Nausea—Metformin—type 2 diabetes mellitus	0.00164	0.00232	CcSEcCtD
Methacholine—Headache—Irbesartan—type 2 diabetes mellitus	0.00163	0.00231	CcSEcCtD
Methacholine—Dizziness—Losartan—type 2 diabetes mellitus	0.00162	0.0023	CcSEcCtD
Methacholine—Vomiting—Losartan—type 2 diabetes mellitus	0.00156	0.00221	CcSEcCtD
Methacholine—Nausea—Irbesartan—type 2 diabetes mellitus	0.00155	0.00219	CcSEcCtD
Methacholine—Headache—Losartan—type 2 diabetes mellitus	0.00154	0.00218	CcSEcCtD
Methacholine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00149	0.00211	CcSEcCtD
Methacholine—Nausea—Losartan—type 2 diabetes mellitus	0.00146	0.00206	CcSEcCtD
Methacholine—Dizziness—Ramipril—type 2 diabetes mellitus	0.00139	0.00197	CcSEcCtD
Methacholine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00134	0.00189	CcSEcCtD
Methacholine—Headache—Ramipril—type 2 diabetes mellitus	0.00132	0.00187	CcSEcCtD
Methacholine—Nausea—Ramipril—type 2 diabetes mellitus	0.00125	0.00177	CcSEcCtD
Methacholine—CHRM3—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000182	0.000678	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000181	0.000675	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.00018	0.000673	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.00018	0.000671	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000178	0.000665	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000177	0.000659	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000174	0.000647	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GLP1R—type 2 diabetes mellitus	0.000172	0.000641	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000172	0.000641	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000169	0.000629	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000167	0.000623	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000167	0.000623	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000166	0.000619	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000165	0.000617	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000164	0.000613	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000161	0.000602	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000161	0.000599	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.00016	0.000597	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.00016	0.000596	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000159	0.000591	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000158	0.000589	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CPT1A—type 2 diabetes mellitus	0.000157	0.000587	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTR—type 2 diabetes mellitus	0.000157	0.000587	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000156	0.000583	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NAMPT—type 2 diabetes mellitus	0.000154	0.000575	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LIPC—type 2 diabetes mellitus	0.000153	0.000572	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HBA1—type 2 diabetes mellitus	0.000153	0.000572	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GCK—type 2 diabetes mellitus	0.000153	0.000572	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000152	0.000568	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.00015	0.00056	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SLC9A1—type 2 diabetes mellitus	0.00015	0.000558	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000149	0.000555	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000149	0.000555	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CETP—type 2 diabetes mellitus	0.000148	0.000551	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000148	0.00055	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000148	0.00055	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000147	0.00055	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000146	0.000545	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000146	0.000545	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000145	0.000542	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000144	0.000537	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000144	0.000536	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000144	0.000536	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000143	0.000535	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000143	0.000535	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.000143	0.000534	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000143	0.000532	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000142	0.000531	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000142	0.000531	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000142	0.00053	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000142	0.00053	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000141	0.000528	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000141	0.000527	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.00014	0.000522	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SNAP25—type 2 diabetes mellitus	0.000137	0.000513	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SREBF1—type 2 diabetes mellitus	0.000137	0.000513	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PSMD6—type 2 diabetes mellitus	0.000137	0.000513	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000136	0.000509	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000135	0.000504	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CTGF—type 2 diabetes mellitus	0.000135	0.000503	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000134	0.000501	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMGCR—type 2 diabetes mellitus	0.000134	0.000499	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000133	0.000496	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000131	0.00049	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000131	0.000488	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.00013	0.000485	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.00013	0.000483	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000128	0.000479	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000128	0.000478	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000127	0.000475	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000127	0.000473	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000127	0.000472	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000126	0.00047	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000126	0.000469	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000125	0.000467	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000125	0.000465	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000124	0.000464	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000124	0.000464	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000124	0.000464	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000124	0.000463	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000124	0.000461	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000124	0.000461	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000123	0.000459	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000123	0.000459	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000122	0.000457	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000122	0.000455	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000121	0.000452	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000121	0.00045	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000119	0.000445	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	0.000119	0.000444	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000119	0.000444	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000118	0.000442	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000118	0.00044	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000117	0.000437	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000115	0.00043	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000115	0.000429	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000115	0.000429	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000114	0.000426	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000114	0.000424	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000114	0.000424	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000113	0.000422	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000112	0.000418	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000112	0.000417	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000111	0.000415	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000111	0.000415	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000111	0.000413	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.00011	0.000411	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.00011	0.000411	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000109	0.000408	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000109	0.000406	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000109	0.000406	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000108	0.000404	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000108	0.000402	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000108	0.000402	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000108	0.000401	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000107	0.000397	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000105	0.00039	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000104	0.000386	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	0.000103	0.000383	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000103	0.000383	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	0.000102	0.000381	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000101	0.000378	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000101	0.000376	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	0.000101	0.000376	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.0001	0.000374	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.99e-05	0.000373	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.97e-05	0.000372	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	9.97e-05	0.000372	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	9.87e-05	0.000368	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.87e-05	0.000368	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.81e-05	0.000366	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	9.8e-05	0.000365	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.77e-05	0.000364	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.71e-05	0.000362	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.68e-05	0.000361	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	9.53e-05	0.000355	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	9.35e-05	0.000349	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	9.33e-05	0.000348	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	9.24e-05	0.000344	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.16e-05	0.000342	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	9.16e-05	0.000341	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	9.16e-05	0.000341	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	9.13e-05	0.00034	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.08e-05	0.000338	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	9.07e-05	0.000338	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	8.89e-05	0.000331	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	8.78e-05	0.000327	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.67e-05	0.000323	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.59e-05	0.00032	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.59e-05	0.00032	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.51e-05	0.000317	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	8.48e-05	0.000316	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.48e-05	0.000316	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.44e-05	0.000315	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	8.42e-05	0.000314	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.4e-05	0.000313	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.39e-05	0.000313	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	8.39e-05	0.000313	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.36e-05	0.000312	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.32e-05	0.00031	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.31e-05	0.00031	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	8.26e-05	0.000308	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.23e-05	0.000307	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	8.19e-05	0.000305	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.16e-05	0.000304	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	8.11e-05	0.000302	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.08e-05	0.000301	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.06e-05	0.000301	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	8e-05	0.000298	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.98e-05	0.000298	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	7.87e-05	0.000293	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	7.84e-05	0.000292	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	7.82e-05	0.000292	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	7.75e-05	0.000289	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	7.75e-05	0.000289	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.66e-05	0.000286	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.58e-05	0.000283	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.34e-05	0.000274	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.27e-05	0.000271	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.21e-05	0.000269	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.14e-05	0.000266	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	7.04e-05	0.000263	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	6.97e-05	0.00026	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	6.83e-05	0.000255	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.72e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.7e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	6.7e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	6.69e-05	0.00025	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.65e-05	0.000248	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.63e-05	0.000247	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	6.63e-05	0.000247	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.58e-05	0.000245	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	6.56e-05	0.000244	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	6.56e-05	0.000244	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.52e-05	0.000243	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	6.49e-05	0.000242	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	6.49e-05	0.000242	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.48e-05	0.000242	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.42e-05	0.000239	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.18e-05	0.000231	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	6.14e-05	0.000229	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.12e-05	0.000228	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	5.87e-05	0.000219	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	5.87e-05	0.000219	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.85e-05	0.000218	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.79e-05	0.000216	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	5.6e-05	0.000209	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	5.55e-05	0.000207	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.51e-05	0.000205	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.46e-05	0.000203	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.42e-05	0.000202	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.41e-05	0.000202	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.39e-05	0.000201	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	5.37e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.36e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.36e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.34e-05	0.000199	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.14e-05	0.000192	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.09e-05	0.00019	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.91e-05	0.000183	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.91e-05	0.000183	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.86e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.86e-05	0.000181	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	4.62e-05	0.000172	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.58e-05	0.000171	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.21e-05	0.000157	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.17e-05	0.000155	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.17e-05	0.000155	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.14e-05	0.000154	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.13e-05	0.000154	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.1e-05	0.000153	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.94e-05	0.000147	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.9e-05	0.000146	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.9e-05	0.000145	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.86e-05	0.000144	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.82e-05	0.000143	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.78e-05	0.000141	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.63e-05	0.000135	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.6e-05	0.000134	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.54e-05	0.000132	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.5e-05	0.000131	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.25e-05	0.000121	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.22e-05	0.00012	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.18e-05	0.000119	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.15e-05	0.000118	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	2.7e-05	0.000101	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.45e-05	9.13e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.42e-05	9.04e-05	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.26e-05	8.42e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.24e-05	8.34e-05	CbGpPWpGaD
